Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Vaccinal Activity Assessment of MenBVac Against Nesseiria Menigitidis B:14,P1.7,16 Strain in Child.

NCT01054053 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT01054053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01054053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Vaccinal Activity Assessment of MenBVac Against Nesseiria Menigitidis B:14,P1.7,16 Strain in Child.
Lead sponsor
University Hospital, Rouen
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
January 31, 2011
Enrollment
218 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccination